/explore

Click through on any links that interest you or select the planets on the right to continue exploring the Outer Web.
You are here

 brighterworld.mcmaster.ca
Researchers to begin human trials for promising new inhaled COVID-19 vaccines designed to combat variants of concern - Brighter World
| | www.wired.com
Front-Runners Emerge in the Race for a Covid-19 Vaccine | WIRED
1.8 parsecs away

Travel
| | Two leading candidates are headed for mass clinical trials, and everything's on the table-including deliberately infecting healthy vaccine volunteers.
| | www.fda.gov
FDA Authorizes Updated Novavax COVID-19 Vaccine Formulated to Better Protect Against Currently Circulating Variants | FDA
2.5 parsecs away

Travel
| | The FDA amended the emergency use authorization of the Novavax COVID-19 Vaccine, Adjuvanted for use in individuals 12 years of age and older to include the 2023-2024 formula. The updated vaccine addresses currently circulating variants to provide better protection against serious consequences of COV
| | news.mcmaster.ca
Researchers to begin human trials for promising new inhaled COVID-19 vaccines designed to combat variants of concern - McMaster News
0.0 parsecs away

Travel
| | Vaccines developed at McMaster target the lungs first. [...]Read More...
| | www.nationalnursesunited.org
Quad-demic: RSV, Influenza, Covid-19, and Crisis Standards of Care | National Nurses United
21.6 parsecs away

Travel
| Currently, rates of influenza and respiratory syncytial virus (RSV) are climbing rapidly across the United States. Pediatric hospitals are full. Hospitalizations for flu are the highest for this time of year in over a decade. This is happening while the Covid-19 pandemic continues.